1
James J Carberry: Composition of olivetol and method of use to reduce or inhibit the effects of tetrahydrocannabinol in the human body. Undoo, Matthew C Lapple, Franklin D Ubell, Lapple Ubell IP Law, March 20, 2018: US09918947

Embodiments of the present invention relate to the use of a therapeutically-effective amount of Olivetol to reduce, eliminate, inhibit or alleviate the psychoactive effects of THC in users of Cannabis. Further embodiments of the present invention relate to a softgel, tablet or capsule of Olivetol in ...


2
Moulton Gregory Hagan, Hamilton Felix: System and method for data protection with multidimensional parity. Undoo, January 2, 2003: EP1269316-A1

A high availability, high reliability storage system (215) that leverages rapid advances in commodity computing devices and the robust nature of internetwork technology such as the Internet (213). A system of parity distribution (505) in accordance with the present invention allows for greater fault ...


3
Composition of Olivetol and Method of Use to Reduce or Inhibit the Effects of Tetrahydrocannabinol in the Human Body. Undoo, May 25, 2017: US20170143643-A1

Embodiments of the present invention relate to the use of a therapeutically-effective amount of Olivetol to reduce, eliminate, inhibit or alleviate the psychoactive effects of THC in users of Cannabis. Further embodiments of the present invention relate to a softgel, tablet or capsule of Olivetol in ...


4
Composition of Olivetol and Method of Use to Reduce or Inhibit the Effects of Tetrahydrocannabinol in the Human Body. Undoo, May 25, 2017: US20170143644-A1

Embodiments of the present invention relate to the use of a therapeutically-effective amount of Olivetol to reduce, eliminate, inhibit or alleviate the psychoactive effects of THC in users of Cannabis. Further embodiments of the present invention relate to a softgel, tablet or capsule of Olivetol in ...


5
Composition of Olivetol and Method of Use to Reduce or Inhibit the Effects of Tetrahydrocannabinol in the Human Body. Undoo, August 23, 2018: US20180235905-A1

Embodiments of the present invention relate to the use of a therapeutically-effective amount of Olivetol to reduce, eliminate, inhibit or alleviate the psychoactive effects of THC in users of Cannabis. Further embodiments of the present invention relate to a softgel, tablet or capsule of Olivetol in ...